Equity benchmarks rebounded 0.2 percent on September 10 after a three-day correction, but market breadth remained weak. About 2,002 shares declined, compared with 1,238 advancing shares on the NSE. The market is expected to remain under bearish pressure amid rising oil prices and fears of a prolonged Iran war. Here are some short-term trading ideas to consider:Mahesh M Ojha, Vice President Researc...

Bulls maintained their control over Dalal Street for another session, driving the Nifty 50 higher by 1.3 percent on November 25, with a positive market breadth. About 1,783 shares gained on the NSE, compared to 744 declining shares. The momentum is expected to remain positive, but considering the 1,000-point rally over the last two sessions, some consolidation cannot be ruled out. Below are some t...

Biocon Biologics said that it has entered into a long-term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.Shares of Biocon fell over 4 percent on March 15 after its subsidiary Biocon Biologics' India-branded formulation business was acquired by Eris Lifesciences, a chronic therapy-focused drug f...

Senior Congress leader Shashi Tharoor on Friday took a dig at the BJP and AAP convener Arvind Kejriwal with a poem over the Delhi Chief Minister’s “mannerless” posture row.The BJP had criticised Kejriwal on Wednesday over his “mannerless” posture during a meeting with Prime Minister Narendra Modi on the Covid situation in the country and questioned whether this is how a chief minis...

NEW DELHI: Shares of Eris Lifesciences NSE 2.74 % skyrocketed 10 per cent in early trading on Monday after the drugmaker said that it formed a joint venture (JV) with Mumbai-based MJ Biopharm to foray into the insulin segment.The news sent the company’s scrip soaring to a high of Rs.774 as against the previous close of Rs705.10. The counter had touched a 52-week high of Rs.863 on October 19.Th...